Workflow
AlloMap
icon
Search documents
CareDx (CDNA) Earnings Call Presentation
2025-06-25 16:40
The Transplant Company™ Focused on improving care across the entire transplant patient journey Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding the future financial position of CareDx®, Inc. (together with its subsidiaries, "CareDx" or the "Company"), including financial targets, business strategy, and plans and objectives for fut ...
CareDx (CDNA) 2025 Earnings Call Presentation
2025-06-25 16:38
The Transplant Solutions Company •J u n e 5 , 2 0 2 5 Click to edit Master text styles Click to edit Master title style Patrick G, Kidney Transplant Recipient Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this presentation, including s ...
CareDx(CDNA) - 2025 Q1 - Earnings Call Transcript
2025-04-30 21:32
CareDx (CDNA) Q1 2025 Earnings Call April 30, 2025 04:30 PM ET Company Participants Caroline Corner - Investor RelationsJohn Hanna - President and CEORobert Woodward - Chief Scientific OfficerAbhishek Jain - CFOKeith Kennedy - Chief Operating OfficerVidyun Bais - Equity Research - Vice PresidentBrandon Couillard - Managing DirectorThomas DeBourcy - PrincipalEduardo Martinez-Montes - Biotechnology Equity Research Associate Conference Call Participants None - AnalystMason Carrico - Research AnalystMatt Stanto ...
CareDx(CDNA) - 2025 Q1 - Earnings Call Presentation
2025-04-30 21:02
The Transplant Solutions Company A P R I L 3 0 , 2 0 2 5 Click to edit Master text styles Click to edit Master title style Patrick G, Kidney Transplant Recipient Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this presentation, includin ...
CareDx(CDNA) - 2025 Q1 - Earnings Call Transcript
2025-04-30 20:30
CareDx (CDNA) Q1 2025 Earnings Call April 30, 2025 04:30 PM ET Speaker0 Good day, everyone, and welcome to today's CareDx First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star one on your telephone keypad. Please note this call may be recorded, and I will be standing by if you should need a ...
CareDx(CDNA) - 2024 Q4 - Earnings Call Transcript
2025-02-27 03:01
CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President and Chief Executive Officer Abhishek Jain - Chief Financial Officer Conference Call Participants Mark Massaro - BTIG Bill Bonello - Craig-Hallum Andrew Cooper - Raymond James Mason Carrico - Stephens Eduardo Martinez - H.C. Wainwright Thomas DeBourcy - Nephron Research Operator Good afternoon, everyone. Welcome to the CareDx, Inc. Fourth Qua ...